Mutational Landscape of the Y Chromosome and Prostate Cancer
Abstract
Mortality from prostate cancer (PC), an estimated 33,330 deaths in 2020, is associated with development of aggressive and treatment-insensitive metastatic castration-resistant prostate cancer (mCRPC). We will investigate the status and role of Y chromosome (ChrY) genes in regulating drug sensitivity and mCRPC development and progression.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2020
- Accession Number
- AD1106340
Entities
People
- Nikolaus Schultz
- Philip W. Kantoff
Organizations
- Sloan-Kettering Institute